-
2024-517785-42-00
5
2020-10-08
Renal cell carcinoma (RCC)
-
2024-517141-13-00
3
2020-10-07
Advanced solid tumors, or hematological malignancies and normal hepati
-
2023-507303-55-00
4
2020-09-30
Alzheimer Disease
-
2023-506527-28-00
5
2020-06-29
Axial Spondyloarthritis
-
2022-502988-37-00
5
2020-06-19
Small cell lung cancer (SCLC)
-
2023-507846-96-00
5
2020-06-19
Type 2 Diabetes Mellitus
-
2022-502482-17-00
5
2020-05-19
Non-small cell lung cancer (NSCLC)
-
2023-507024-24-00
5
2020-05-05
Metastatic hormone sensitive prostate cancer
-
2022-501018-78-00
5
2020-03-23
Axial Spondyloarthritis
-
2022-502361-15-00
5
2019-12-12
Moderate-to-Severe Plaque Psoriasis
-
2022-503050-39-00
5
2019-11-12
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) w
-
2023-507148-35-00
5
2019-10-03
Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastroint
-
2023-505614-17-00
5
2019-09-20
Participants with advanced or recurrent endometrial carcinoma
-
2022-502858-14-00
5
2019-09-05
Hypertrophic cardiomyopathy
-
2024-511972-33-00
5
2019-08-05
Primary myelofibrosis, post-polycythemia vera myelofibrosis , or post-
-
2022-502801-13-00
4
2019-07-26
Epileptic Encephalopathies: Dravet Syndrome, Lennox Gastaut Syndrome,
-
2023-508022-10-00
6
2019-07-25
Rheumatoid Arthritis
-
2023-504928-26-00
5
2019-07-19
Chronic Migraine
-
2023-508449-41-00
5
2019-06-26
Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
-
2023-509774-40-00
5
2019-06-25
Stage IV lung cancer condition
-
2022-502444-13-00
4
2019-05-28
Systemic Lupus Erythematosus
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2023-509304-16-00
5
2019-05-16
Pulmonary arterial hypertension (PAH)
-
2022-502124-52-00
5
2018-12-18
Advanced epithelial ovarian cancer